Chongqing Zhifei Biological Products Co., Ltd.
300122
Rank in Stocks
#3688
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Share Price
$1.91
Market Cap
$4.57B
Change (1 day)
5.32%
Change (1 year)
-32.90%
Country
CN
Trade Chongqing Zhifei Biological Products Co., Ltd. (300122)
Category
Healthcare
Revenue for Chongqing Zhifei Biological Products Co., Ltd. (300122)
Revenue in Jun 2026 TTM: $1.17B
According to Chongqing Zhifei Biological Products Co., Ltd. latest financial reports the company's current revenue (TTM) is $1.17B. In 2023 the company made a revenue of $7.48B an increase over the revenue in the year 2022 that was $5.55B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Chongqing Zhifei Biological Products Co., Ltd. from 2007 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.17B | -67.29% |
| 2024 | $3.57B | -52.22% |
| 2023 | $7.48B | 34.77% |
| 2022 | $5.55B | 15.02% |
| 2021 | $4.82B | 107.40% |
| 2020 | $2.33B | 52.93% |
| 2019 | $1.52B | 100.04% |
| 2018 | $760.08M | 268.34% |
| 2017 | $206.35M | 221.27% |
| 2016 | $64.23M | -41.48% |
| 2015 | $109.76M | -15.12% |
| 2014 | $129.31M | 0.54% |
| 2013 | $128.62M | 5.49% |
| 2012 | $121.93M | 22.25% |
| 2011 | $99.73M | -10.72% |
| 2010 | $111.71M | 26.26% |
| 2009 | $88.48M | 3.92% |
| 2008 | $85.14M | 26.24% |
| 2007 | $67.44M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | 980.44% |
US
|
|
| $2.23B | 90.68% |
US
|
|
| $15.74B | 1,247.47% |
AU
|
|
| $6.02B | 415.33% |
NL
|
|
| - | - |
CH
|
